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Gap junctions (GJ) mediate electrical coupling between cardiac myocytes, allow-
ing the spreading of the electrical wave responsible for synchronized contraction [1]. 
GJ function can be regulated by modulation of connexon densities on membranes, 
connexin (Cx) phosphorylation, trafficking and degradation. Recent studies showed 
that adenosine involves Cx43 turn-over in A1 receptor-dependent manner [2], and 
dipyridamole increases GJ coupling and amount of Cx43 in endothelial cells [3].
As the abnormalities in GJ organization and regulation have been implicated in 
diseased myocardium [1], the aim of the present study was to assess the regional 
expression of molecules involved in GJ regulation in a model of left ventricular dis-
function (LVD). For this purpose the distribution and quantitative expression of Cx43, 
its phosphorylated form pS368-Cx43, PKC phosphorylated substrates, RhoA and 
A receptors, were investigated in experimental models of right ventricular-pacing 
induced LVD, undergoing concomitant dipyridamole therapy or placebo, and com-
pared with healty myocardium obtained from sham operated minipigs.
Results demonstrates that an altered pattern of factors involved in Cx43-made GJ 
regulation is present in ventricular myocardium with left ventricular dysfunction. 
Moreover, the dipyridamole treatment, that results in an improvement of heart func-
tion, seems to act also modulating expression and activation of these factors. 
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